Thank you for the question.
You have visited Toronto, so I speculate that you have seen first-hand the ultrasound devices that are being developed there. We're trying to adapt the technology to work in the theatre of operation, to be able to enhance the 3-D ultrasound diagnostic tools that are available to medics on site. That technology is still in development. This is work that we continue to do to make that technology portable, rugged enough to be able to deploy, and reliable enough, of course, to deploy in theatre.
Another example that comes from Toronto is the formulation of a new intravenous saline treatment that is administered. Especially when a soldier has experienced loss of blood and loss of fluids, we need to inject saline, an IV as we call it. We have modified the saline package to be able to make it more portable, and that solution is now deployed in theatre. It is a technology that was developed through DRDC and is now deployed in theatre.
As you asked about the training that we provide, we're also working to support deployment of our troops by training them to deal with live agents, with toxins and chemical and bacterial warfare agents, again, a concern in the context of Syria. This is an example of how we adjust our research program to make sure that our men and women in uniform are best equipped to deal with whatever threat they're going to be faced with. In Suffield we do work on protection against chemical and biological warfare agents. The military can be exposed to conditions simulating those agents and we train them to properly deal with those things.
Lieutenant-Colonel Tremblay, do you want to add anything?